Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Killander

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-groupB Simonsson, G Oberg, A Killander, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, A Killander, et al.
Haemostasis|January 1, 1996
Clinical experience with recombinant factor VIIa in patients with thrombocytopeniaJ Kristensen, A Killander, E Hippe, et al.
Cancer|August 1, 1974
Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemiaG Gahrton, L Engstedt, S Franzén, et al.
European Journal of Haematology|September 13, 2002
Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapyG Oberg, A Killander, M Björeman, et al.
Scandinavian Journal of Haematology|August 1, 1975
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemiaA M Udén, G Brenning, L Engstedt, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaA Ahre, M Björkholm, H Mellstedt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemiaB Lönnqvist, B Andersson, M Björkholm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemiaC Paul, M Björkholm, I Christenson, et al.
Cancer|January 1, 1976
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemiaD Killander, A Dohlwitz, L Engstedt, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-groupB Simonsson, G Oberg, A Killander, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, A Killander, et al.
Haemostasis|January 1, 1996
Clinical experience with recombinant factor VIIa in patients with thrombocytopeniaJ Kristensen, A Killander, E Hippe, et al.
Cancer|August 1, 1974
Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemiaG Gahrton, L Engstedt, S Franzén, et al.
European Journal of Haematology|September 13, 2002
Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapyG Oberg, A Killander, M Björeman, et al.
Scandinavian Journal of Haematology|August 1, 1975
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemiaA M Udén, G Brenning, L Engstedt, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaA Ahre, M Björkholm, H Mellstedt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemiaB Lönnqvist, B Andersson, M Björkholm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemiaC Paul, M Björkholm, I Christenson, et al.
Cancer|January 1, 1976
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemiaD Killander, A Dohlwitz, L Engstedt, et al.
Pageof 7